[ad_1]
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. World most cancers statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 international locations. CA Most cancers J Clin. 2021;71(3):209–49.
Chow LQM. Head and neck most cancers. N Engl J Med. 2020;382(1):60–72.
Osazuwa-Peters N, Simpson MC, Zhao L, Boakye EA, Olomukoro SI, Deshields T, Loux TM, Varvares MA, Schootman M. Suicide threat amongst most cancers survivors: head and neck versus different cancers. Most cancers. 2018;124(20):4072–9.
Cramer JD, Burtness B, Ferris RL. Immunotherapy for head and neck most cancers: current advances and future instructions. Oral Oncol. 2019;99:104460.
Budach W, Bölke E, Kammers Ok, Gerber PA, Orth Ok, Gripp S, Matuschek C. Induction chemotherapy adopted by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as remedy of regionally superior squamous cell carcinoma of the top and neck (HNSCC): a meta-analysis of randomized trials. Radiother Oncol. 2016;118(2):238–43.
Siegel RL, Miller KD, Jemal A. Most cancers statistics, 2018. CA Most cancers J Clin. 2018;68(1):7–30.
Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Prim. 2020;6(1):92.
Cai L, Xu J, Yang Z, Tong R, Dong Z, Wang C, Leong KW. Engineered biomaterials for most cancers immunotherapy. MedComm. 2020;1(1):35–46.
Teong SP, Zhang Y. Calcium carbide and its current advances in biomass conversion. J Bioresour Bioprod. 2020;5(2):96–100.
Xia Z, Li J, Zhang J, Zhang X, Zheng X, Zhang J. Processing and valorization of cellulose, lignin and lignocellulose utilizing ionic liquids. J Bioresour Bioprod. 2020;5(2):79.
Olusanya TO, Haj Ahmad RR, Ibegbu DM, Smith JR, Elkordy AA. Liposomal drug supply programs and anticancer medicine. Molecules. 2018;23(4):907.
Rao L, Bu L-L, Meng Q-F, Cai B, Deng W-W, Li A, Li Ok, Guo S-S, Zhang W-F, Liu W, Solar Z-J, Zhao X-Z. Antitumor platelet-mimicking magnetic nanoparticles. Adv Funct Mater. 2017;27(9):1604774.
Tao W, Zeng X, Wu J, Zhu X, Yu X, Zhang X, Zhang J, Liu G, Mei L. Polydopamine-based floor modification of novel nanoparticle-aptamer bioconjugates for in vivo breast most cancers focusing on and enhanced therapeutic results. Theranostics. 2016;6(4):470–84.
Sur S, Rathore A, Dave V, Reddy KR, Chouhan RS, Sadhu V. Latest developments in functionalized polymer nanoparticles for environment friendly drug supply system. Nano-Struct Nano-Objects. 2019;20:100397.
Li Z, Barnes JC, Bosoy A, Stoddart JF, Zink JI. Mesoporous silica nanoparticles in biomedical purposes. Chem Soc Rev. 2012;41(7):2590–605.
Elzoghby AO, Hemasa AL, Freag MS. Hybrid protein-inorganic nanoparticles: from tumor-targeted drug supply to most cancers imaging. J Management Launch. 2016;243:303–22.
Dong Z, Feng L, Hao Y, Chen M, Gao M, Chao Y, Zhao H, Zhu W, Liu J, Liang C, Zhang Q, Liu Z. Synthesis of hole biomineralized CaCO(3)-polydopamine nanoparticles for multimodal imaging-guided most cancers photodynamic remedy with decreased pores and skin photosensitivity. J Am Chem Soc. 2018;140(6):2165–78.
Zhao H, Feng H, Liu D, Liu J, Ji N, Chen F, Luo X, Zhou Y, Dan H, Zeng X, Li J, Solar C, Meng J, Ju X, Zhou M, Yang H, Li L, Liang X, Chu L, Jiang L, He Y, Chen Q. Self-assembling monomeric nucleoside molecular nanoparticles loaded with 5-FU enhancing therapeutic efficacy towards oral most cancers. ACS Nano. 2015;9(10):9638–51.
Wang F, Wang YC, Dou S, Xiong MH, Solar TM, Wang J. Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug supply for overcoming multidrug resistance in most cancers cells. ACS Nano. 2011;5(5):3679–92.
Xie W, Deng WW, Zan M, Rao L, Yu GT, Zhu DM, Wu WT, Chen B, Ji LW, Chen L, Liu Ok, Guo SS, Huang HM, Zhang WF, Zhao X, Yuan Y, Dong W, Solar ZJ, Liu W. Most cancers cell membrane camouflaged nanoparticles to comprehend hunger remedy along with checkpoint blockades for enhancing most cancers remedy. ACS Nano. 2019;13(3):2849–57.
Han, X., S. Shen, Q. Fan, G. Chen, E. Archibong, G. Dotti, Z. Liu, Z. Gu, and C. Wang, Crimson blood cell-derived nanoerythrosome for antigen supply with enhanced most cancers immunotherapy. Sci Adv, 2019. 5(10): p. eaaw6870.
Chen Q, Wang C, Zhang X, Chen G, Hu Q, Li H, Wang J, Wen D, Zhang Y, Lu Y, Yang G, Jiang C, Wang J, Dotti G, Gu Z. In situ sprayed bioresponsive immunotherapeutic gel for post-surgical most cancers remedy. Nat Nanotechnol. 2019;14(1):89–97.
Zhu X, Tao W, Liu D, Wu J, Guo Z, Ji X, Bharwani Z, Zhao L, Zhao X, Farokhzad OC, Shi J. Floor De-PEGylation controls nanoparticle-mediated siRNA supply in vitro and in vivo. Theranostics. 2017;7(7):1990–2002.
Gao LY, Liu XY, Chen CJ, Wang JC, Feng Q, Yu MZ, Ma XF, Pei XW, Niu YJ, Qiu C, Pang WH, Zhang Q. Core-shell kind lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA supply. Biomaterials. 2014;35(6):2066–78.
Chen WH, Yang CX, Qiu WX, Luo GF, Jia HZ, Lei Q, Wang XY, Liu G, Zhuo RX, Zhang XZ. Multifunctional theranostic nanoplatform for most cancers mixed remedy based mostly on gold nanorods. Adv Healthc Mater. 2015;4(15):2247–59.
Yusuf A, Casey A. Floor modification of silver nanoparticle (AgNP) by liposomal encapsulation mitigates AgNP-induced irritation. Toxicol In Vitro. 2019;61:104641.
Hong S, Choi DW, Kim HN, Park CG, Lee W, Park HH. Protein-based nanoparticles as drug supply programs. Pharmaceutics. 2020;12(7):604.
Xu X, Wang Y, Lauer-Fields JL, Fields GB, Steffensen B. Contributions of the MMP-2 collagen binding area to gelatin cleavage. Substrate binding by way of the collagen binding area is required for hydrolysis of gelatin however not brief peptides. Matrix Biol. 2004;23(3):171–81.
Saito M, Kimoto M, Araki T, Shimada Y, Fujii R, Oofusa Ok, Conceal M, Usui T, Yoshizato Ok. Proteome evaluation of gelatin-bound urinary proteins from sufferers with bladder cancers. Eur Urol. 2005;48(5):865–71.
Xu JH, Gao FP, Liu XF, Zeng Q, Guo SS, Tang ZY, Zhao XZ, Wang H. Supramolecular gelatin nanoparticles as matrix metalloproteinase responsive most cancers cell imaging probes. Chem Commun. 2013;49(40):4462–4.
Zou Z, He X, He D, Wang Ok, Qing Z, Yang X, Wen L, Xiong J, Li L, Cai L. Programmed packaging of mesoporous silica nanocarriers for matrix metalloprotease 2-triggered tumor focusing on and launch. Biomaterials. 2015;58:35–45.
Ruan S, He Q, Gao H. Matrix metalloproteinase triggered size-shrinkable gelatin-gold fabricated nanoparticles for tumor microenvironment delicate penetration and analysis of glioma. Nanoscale. 2015;7(21):9487–96.
Chen X, Zou J, Zhang Ok, Zhu J, Zhang Y, Zhu Z, Zheng H, Li F, Piao JG. Photothermal/matrix metalloproteinase-2 dual-responsive gelatin nanoparticles for breast most cancers remedy. Acta Pharm Sin B. 2021;11(1):271–82.
Bu LL, Yu GT, Wu L, Mao L, Deng WW, Liu JF, Kulkarni AB, Zhang WF, Zhang L, Solar ZJ. STAT3 induces immunosuppression by upregulating PD-1/PD-L1 in HNSCC. J Dent Res. 2017;96(9):1027–34.
Chen Q, Liang C, Wang C, Liu Z. An imagable and photothermal “abraxane-like” nanodrug for mixture most cancers remedy to deal with subcutaneous and metastatic breast tumors. Adv Mater. 2015;27(5):903–10.
Yang R, Hou M, Gao Y, Lu S, Zhang L, Xu Z, Li CM, Kang Y, Xue P. Biomineralization-inspired crystallization of manganese oxide on silk fibroin nanoparticles for in vivo MR/fluorescence imaging-assisted tri-modal remedy of most cancers. Theranostics. 2019;9(21):6314–33.
Yang W, Guo W, Le W, Lv G, Zhang F, Shi L, Wang X, Wang J, Wang S, Chang J, Zhang B. Albumin-bioinspired Gd:CuS nanotheranostic agent for in vivo photoacoustic/magnetic resonance imaging-guided tumor-targeted photothermal remedy. ACS Nano. 2016;10(11):10245–57.
Ma Y, Zhang Y, Li X, Zhao Y, Li M, Jiang W, Tang X, Dou J, Lu L, Wang F, Wang Y. Close to-infrared II phototherapy induces deep tissue immunogenic cell demise and potentiates most cancers immunotherapy. ACS Nano. 2019;13(10):11967–80.
Kalyane D, Raval N, Maheshwari R, Tambe V, Kalia Ok, Tekade RK. Employment of enhanced permeability and retention impact (EPR): nanoparticle-based precision instruments for focusing on of therapeutic and diagnostic agent in most cancers. Mater Sci Eng C Mater Biol Appl. 2019;98:1252–76.
Li LL, Xu JH, Qi GB, Zhao X, Yu F, Wang H. Core-shell supramolecular gelatin nanoparticles for adaptive and “on-demand” antibiotic supply. ACS Nano. 2014;8(5):4975–83.
Marcazzan, S., E.M. Varoni, E. Blanco, G. Lodi, and M. Ferrari, Nanomedicine, an rising therapeutic technique for oral most cancers remedy. Oral Oncol, 2018. 76: p. 1–7.
Bian Y, Corridor B, Solar ZJ, Molinolo A, Chen W, Gutkind JS, Waes CV, Kulkarni AB. Lack of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma by way of mobile senescence evasion and cancer-related irritation. Oncogene. 2012;31(28):3322–32.
Yang L, Edwards CM, Mundy GR. Gr-1+CD11b+ myeloid-derived suppressor cells: formidable companions in tumor metastasis. J Bone Miner Res. 2010;25(8):1701–6.
Sharpe AH, Pauken KE. The various capabilities of the PD1 inhibitory pathway. Nat Rev Immunol. 2018;18(3):153–67.
Wu L, Deng W-W, Yu G-T, Mao L, Bu L-L, Ma S-R, Liu B, Zhang W-F, Solar Z-J. B7–H4 expression signifies poor prognosis of oral squamous cell carcinoma. Most cancers Immunol Immunother. 2016;65(9):1035–45.
[ad_2]
